Medically Supervised Peptide Care

Human Growth Hormone Peptide Therapy Personalized Evaluation and Clinical Guidance

Name: Alpha Hormones Inc.
Price range: $$$

Explore medically supervised peptide options that may support appropriate hormone-related health goals. Care begins with a provider evaluation and is based on your medical history, laboratory findings, eligibility, and ongoing monitoring.

Provider evaluation
Individualized care planning
Ongoing clinical monitoring

Schedule a Consultation

Growth Hormone Education

What Is HGH Peptide Therapy?

HGH peptide therapy uses peptides, or short chains of amino acids, that interact with receptors in the body. Some signal the pituitary gland to release the body’s own growth hormone. They do not supply recombinant human growth hormone directly.

Growth hormone helps regulate metabolism, tissue health, and body composition. The amount the body releases changes with age, sleep, diet, illness, and other health factors. However, symptoms alone cannot diagnose adult growth hormone deficiency. A clinician must assess your health and select appropriate tests.

Recombinant human growth hormone is tightly regulated and approved only for specific medical conditions. Alpha Hormones® does not prescribe HGH for unapproved anti-aging or general wellness use. When clinically and legally appropriate, our team can assess whether an FDA-approved therapy or another peptide-related option meets applicable standards.

Important distinction: Growth hormone–releasing peptides are not HGH. Their indications, evidence, regulatory status, expected effects, and risks differ by medication.

Educational graphic showing growth hormone levels changing with age

Clinical Evaluation

Symptoms That May Warrant Evaluation

These concerns are common and may have many causes. They do not establish growth hormone deficiency on their own.

Reduced muscle mass or strength
Lower exercise capacity
Slower recovery
Low energy
Changes in body composition
Reduced bone density
Sleep concerns
Changes in cognitive or emotional well-being

Therapy Overview

Peptides That Affect Growth Hormone Signaling

The medications below have different regulatory histories and should not be presented as interchangeable anti-aging treatments.

Diagram of the hypothalamic, pituitary, growth hormone, and IGF-1 signaling pathway

Available through compounding

Sermorelin

Sermorelin is a synthetic analog of the first 29 amino acids of growth hormone–releasing hormone. It stimulates pituitary growth hormone release through normal signaling pathways and produces a pulsatile response rather than supplying HGH directly.

Sermorelin may be available as a compounded prescription when permitted by law and appropriate for an individually identified patient. Compounded preparations are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness, or quality. A medical evaluation is still required before prescribing.

FDA-approved medication

Tesamorelin

Tesamorelin is an FDA-approved growth hormone–releasing factor analog that stimulates pituitary growth hormone secretion and increases IGF-1. Its approved labeling is limited and it is not approved as a general anti-aging or weight-management medication.

Whether tesamorelin is relevant depends on the patient’s diagnosis, medical history, goals, and potential risks. Any use outside FDA-approved labeling requires an individualized clinical rationale, informed consent, and appropriate follow-up.

Potential Benefits

What Patients May Hope to Improve

When a therapy is clinically appropriate, some patients may notice improvements in areas influenced by growth hormone signaling. Response varies by diagnosis, medication, baseline health, sleep, nutrition, activity, and treatment duration.

Educational infographic describing body systems influenced by growth hormone

Body Composition

Selected patients may experience favorable changes in visceral fat or lean body mass, depending on the medication and indication.

Recovery and Exercise

Some patients report changes in recovery, exercise tolerance, or physical well-being when an underlying deficiency or appropriate indication is addressed.

Sleep Quality

Sleep may improve for some patients. However, a clinician should also assess sleep apnea and other common causes of poor sleep.

Energy and Mental Clarity

Energy, focus, motivation, and quality of life may change over time. Many health and lifestyle factors also affect these concerns.

Bone, Skin, and Tissue Health

Growth hormone pathways contribute to bone and tissue metabolism. Meaningful changes generally take time and need clinical review.

Metabolic Measures

Certain therapies may affect waist size, IGF-1, or other metabolic markers. Your clinician reviews these alongside blood sugar and heart health.

Realistic expectations: These are potential areas of response, not guaranteed outcomes or a fixed timeline. The expected benefit depends on the specific treatment and why it is being prescribed.

Examples of Follow-Up Checks Over Six Months

Month 1: Establishing a Baseline

Track sleep quality and energy
Review injection technique and adherence
Monitor early tolerability
Record recovery and activity levels

Month 2: Early Response

Compare sleep and recovery with baseline
Review energy and exercise tolerance
Assess swelling, joint symptoms, or headaches
Adjust the plan when clinically indicated

Month 3: Clinical Review

Reassess symptoms and quality of life
Review IGF-1 or metabolic testing when relevant
Compare strength and body measurements
Confirm that benefits justify continued treatment

Month 4: Trend Assessment

Evaluate whether progress is sustained
Review recovery and physical function
Discuss plateaus or changing goals
Continue monitoring tolerability

Month 5: Longer-Term Changes

Review waist or body-composition trends
Assess skin, sleep, and general well-being
Reinforce nutrition, activity, and recovery
Review laboratory trends when appropriate

Month 6: Continue or Refine

Complete a broader benefit-risk review
Confirm that treatment goals remain meaningful
Modify dose or strategy when appropriate
Plan the next monitoring interval

The order and timing of changes vary considerably. Some patients may notice no meaningful improvement, and claims involving eyesight, immunity, hair regrowth, wound healing, cellulite removal, or disappearance of pain are not presented as expected treatment outcomes.

What to Expect

A Clinically Guided Evaluation Process

There is no reliable week-by-week timeline that applies to every patient. Care begins with determining whether treatment is indicated and safe.

Medical Review

Discuss symptoms, diagnoses, medications, sleep, nutrition, exercise, and treatment goals.

Appropriate Testing

Obtain targeted laboratory evaluation when clinically indicated; random growth hormone levels alone are not diagnostic.

Shared Decision

Review the evidence, regulatory status, alternatives, potential risks, cost, and realistic expectations.

Ongoing Monitoring

Reassess symptoms, IGF-1 when relevant, glucose control, side effects, and whether continued therapy remains appropriate.

Measured Over Time

How We Assess Response

If therapy is appropriate, we assess your response over time. Results do not follow a fixed schedule. The goal is meaningful clinical improvement while keeping lab values within an appropriate range.

SymptomsWe compare energy, sleep, recovery, and quality of life with your baseline measures.

Body compositionYour clinician reviews changes in waist size, lean mass, and other relevant measures alongside diet and activity.

Laboratory markersFollow-up may include IGF-1 and metabolic markers when relevant to your medication and diagnosis.

TolerabilityOur team promptly reviews swelling, joint symptoms, numbness, headaches, blood sugar changes, and other concerns.

Safety and Monitoring

Thoughtful Care and Follow-Up

Growth hormone signaling influences several tissues and metabolic pathways. A measured approach helps match treatment to a meaningful clinical goal while keeping hormone levels and overall health in view.

Review medical history, pituitary health, pregnancy status, and factors that may influence treatment selection.
Monitor glucose control, fluid retention, joint symptoms, nerve symptoms, and sleep quality when relevant.
Use only medications obtained through lawful, appropriately regulated channels.
Set realistic goals for body composition, recovery, energy, and other patient priorities.
Adjust the plan when the response, laboratory findings, or tolerability indicate that a change would be helpful.

Patient discussing peptide therapy and health goals with a medical provider

Your Next Step

Is Peptide Therapy Right for You?

First, meet with our medical team to review your symptoms, health history, and goals. We can then discuss appropriate testing and whether a clinically and legally available option fits your needs.

Book an Appointment

This content is for general education and does not replace medical advice, diagnosis, or treatment. Peptide products differ in approval status, evidence, quality, and legal availability. Treatment eligibility, risks, benefits, and results vary. No outcome is guaranteed.

Our Mission

Helping patients understand and optimize their health through personalized, evidence-based medicine focused on hormone health, longevity, and lasting well-being.